Canna-V-Cell Sciences Inc. announces Israel health ministry approval

Vancouver, British Columbia--(Newsfile Corp. - November 19, 2018) - Canna-V-Cell Sciences Inc. (CSE: CNVC) (the "CannaVcell") CannaVcell, in its aim to develop and produce Cannabis active ingredients on the basis of the biofarming technology, is announcing that it has received through its subsidiary in Israel, the authorization of the health ministry of Israel to conduct research and development with Cannabis plants. "This is a major milestone in the adaptation of the cell growth technology...

2018-11-19 8:30 AM EST